Efficacy News and Research

RSS
TessArae's RM-Flu test granted FDA EUA

TessArae's RM-Flu test granted FDA EUA

CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial

CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial

Organogenesis files a PMA with the FDA for its CelTx living cell-based technology

Organogenesis files a PMA with the FDA for its CelTx living cell-based technology

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Embryo biopsy does not adversely affect health of newborn singleton PGD/PGS children

Embryo biopsy does not adversely affect health of newborn singleton PGD/PGS children

Taro Pharmaceutical Industries initiates its T2007 non-sedating barbiturate compound Phase I clinical trials

Taro Pharmaceutical Industries initiates its T2007 non-sedating barbiturate compound Phase I clinical trials

Recent releases in Global Health

Recent releases in Global Health

John Theurer Cancer Center presents over 20 research updates and trial results at the 2009 ASH meeting

John Theurer Cancer Center presents over 20 research updates and trial results at the 2009 ASH meeting

U.S. health officials announce shift in focus of prep trial in Botswana

U.S. health officials announce shift in focus of prep trial in Botswana

Flamel Technologies initiates IFN-alpha-2b XL Phase 2a clinical trial for HCV

Flamel Technologies initiates IFN-alpha-2b XL Phase 2a clinical trial for HCV

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Joe Chimera, the 25th person to receive MEP Certification from PHII

Joe Chimera, the 25th person to receive MEP Certification from PHII

Vion Pharmaceuticals files for bankruptcy

Vion Pharmaceuticals files for bankruptcy

FDA advisory committee votes against approval of Tarceva for lung cancer treatment

FDA advisory committee votes against approval of Tarceva for lung cancer treatment

Treprostinil drug reduces breathlessness in PAH patients, says study

Treprostinil drug reduces breathlessness in PAH patients, says study

ARIAD Pharmaceuticals completes enrollment of patients for Phase 3 clinical trial of ridaforolimus

ARIAD Pharmaceuticals completes enrollment of patients for Phase 3 clinical trial of ridaforolimus

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

St. Jude Medical applauds the updated level of evidence for FFR-guided treatment

St. Jude Medical applauds the updated level of evidence for FFR-guided treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.